Covid


Videos

ICMR to use drones for Covid-19 vaccine delivery in Andaman & Nicobar Islands, Manipur, and Nagaland
ICMR to use drones for Covid-19 vaccine delivery in Andaman & Nicobar Islands, Manipur, and Nagaland

This project could help in navigating difficult terrain and reaching inaccessible areas

India administers 100 million Covid-19 vaccine doses in just 13 days
India administers 100 million Covid-19 vaccine doses in just 13 days

India’s Covid-19 vaccination coverage has now crossed the milestone of 700 million cumulative doses

India reports less than 1 lakh daily new cases after 63 days
India reports less than 1 lakh daily new cases after 63 days

The number of patients who recovered during the last 24 hours was 1,82,282

'Proper ventilation of indoor spaces can prevent Covid-19 spread'
'Proper ventilation of indoor spaces can prevent Covid-19 spread'

Ventilation can be a community defense against Covid-19, says Principal Scientific Advisor to Government of India

India uses its resources to fight Covid-19, speeds up oxygen supplies to hospitals
India uses its resources to fight Covid-19, speeds up oxygen supplies to hospitals

Overcoming all hurdles and finding new solutions, India continues to ensure that no Covid-19 patients die due to non- availability of oxygen

Here is how B Medical Systems' cold storage units will boost India's fight against Covid-19
Here is how B Medical Systems' cold storage units will boost India's fight against Covid-19

In an exclusive interview with INN, India CEO of Luxembourg based B Medical Systems Jesal Doshi answers all questions related to the importance of vaccine cold storage units and how the company will play a big role in fighting the pandemic in India

COVID-19 vaccine registration opens for 18+ on April 28: Here is how to register
COVID-19 vaccine registration opens for 18+ on April 28: Here is how to register

The rush at vaccination centres is expected to increase sharply in view of India’s ambitious move to expand the vaccination programme

Covid-19 vaccination open to all above 18 years from May 1
Covid-19 vaccination open to all above 18 years from May 1

The vaccine procurement policy has been liberalised to allow manufacturers to supply upto 50% of their supply to the centre and 50% to states and the open market.

100 new hospitals to have their own oxygen plant under PM-CARES Fund
100 new hospitals to have their own oxygen plant under PM-CARES Fund

A meeting of Empowered Group 2 (EG2) was held on Thursday to review the availability of essential medical equipment and oxygen

India fast tracks regulatory mechanism for Coronavirus vaccines’ approval
India fast tracks regulatory mechanism for Coronavirus vaccines’ approval

In view of surge in Covid-19 cases, the government has facilitated quicker access to foreign vaccines by India

 India braves second wave with grit and determination
India braves second wave with grit and determination

With India braving the second wave of Covid-19 pandemic, efforts to control the spread of the deadly virus have been speeded up

India’s cumulative Covid-19 vaccination coverage crosses 90 million doses
India’s cumulative Covid-19 vaccination coverage crosses 90 million doses

Globally, India leads with an average of more than 34 lakh (3.4 million) doses administered per day

Afghanistan receives Covishield vaccines from India
Afghanistan receives Covishield vaccines from India

Half million doses of COVID-19 vaccine gifted by India to the people of Afghanistan arrived in Kabul on Sunday

 Is Covid-19 vaccine safe? All questions answered with Dr VM Katoch
Is Covid-19 vaccine safe? All questions answered with Dr VM Katoch

The former Director General of Indian Council of Medical Research has answered all questions related to the Covid-19 vaccination drive in India

The start to the end of Covid-19 : India kicks off largest vaccination drive
The start to the end of Covid-19 : India kicks off largest vaccination drive

India launched the world's largest vaccination drive today using two vaccines manufactured in the country, Covidshield and Covaxin

Transport of Covid-19 vaccine begins, vaccination preparations reviewed by PM Modi
Transport of Covid-19 vaccine begins, vaccination preparations reviewed by PM Modi

Manufacturers, airports, and airlines have made arrangements to transport the vaccines at the requisite temperature

New fast-spreading Covid strain found in UK not seen in India yet: Government
New fast-spreading Covid strain found in UK not seen in India yet: Government

The new strain will not have a negative impact on the vaccines being developed, including the indigenous ones

PM Modi visits COVID-19 vaccine development facilities in three cities, briefed on progress
PM Modi visits COVID-19 vaccine development facilities in three cities, briefed on progress

He was briefed on vaccine development by Zydus Cadila, Bharat Biotech, and SII

 India fights Covid-19: Aarogya Setu apps crosses 16 crore downloads
India fights Covid-19: Aarogya Setu apps crosses 16 crore downloads

India has the highest recovery rate globally with Daman and Diu and Dadar and Nagar Haveli, Andaman and Nicobar, and Bihar in the top three

Covid-19 Vaccine: Countries need to come together and pool resources, says WHO
Covid-19 Vaccine: Countries need to come together and pool resources, says WHO

The World Health Organisation’s Covax facility will try to ensure equitable distribution of Covid-19 vaccines

Indian Media

World Bank praises Dharavi’s example in its latest report about COVID-19
World Bank praises Dharavi’s example in its latest report about COVID-19

In July, the World Health Organisation (WHO) had also praised Dharavi for bringing COVID-19 under control

Covid-19 vaccine: Russia ties up with Indian pharma major for large-scale trials
Covid-19 vaccine: Russia ties up with Indian pharma major for large-scale trials

The Russian Direct Investment Fund (RDIF) is in talks with Indian company for large scale human trials of SputnikV vaccine

لقاح Covid-19: تتعاون روسيا مع شركة الأدوية الهندية الكبرى لإجراء تجارب على نطاق واسع
لقاح Covid-19: تتعاون روسيا مع شركة الأدوية الهندية الكبرى لإجراء تجارب على نطاق واسع

يجري صندوق الاستثمار المباشر الروسي (RDIF) محادثات مع شركة هندية لإجراء تجارب بشرية واسعة النطاق للقاح SputnikV

কোভিড -১৯ ভ্যাকসিন: বড় আকারের পরীক্ষার জন্য রাশিয়া ভারতীয় ফার্মা মেজর সাথে সম্পর্ক স্থাপন করেছে
কোভিড -১৯ ভ্যাকসিন: বড় আকারের পরীক্ষার জন্য রাশিয়া ভারতীয় ফার্মা মেজর সাথে সম্পর্ক স্থাপন করেছে

রাশিয়ান প্রত্যক্ষ বিনিয়োগ তহবিল (আরডিআইএফ) স্পুটনিকভি ভ্যাকসিনের বৃহত আকারে মানবিক পরীক্ষার জন্য ভারতীয় সংস্থার সাথে আলোচনা করছে

Covid-19-Impfstoff: Russland schließt sich für groß angelegte Studien mit dem indischen Pharmamajor zusammen
Covid-19-Impfstoff: Russland schließt sich für groß angelegte Studien mit dem indischen Pharmamajor zusammen

Der russische Direktinvestitionsfonds (RDIF) befindet sich in Gesprächen mit einem indischen Unternehmen für groß angelegte Versuche am Menschen mit SputnikV-Impfstoffen

Foreign Media

Three COVID-19 vaccines at clinical trial stage, two have completed phase 1 trial in India: ICMR DG
Three COVID-19 vaccines at clinical trial stage, two have completed phase 1 trial in India: ICMR DG

Serum Institute of India (SII) has completed phase II-B3 trials and will start phase-III trial after clearances

ثلاثة لقاحات COVID-19 في مرحلة التجارب السريرية ، أكمل اثنان المرحلة الأولى من التجربة في الهند: ICMR DG
ثلاثة لقاحات COVID-19 في مرحلة التجارب السريرية ، أكمل اثنان المرحلة الأولى من التجربة في الهند: ICMR DG

أكمل معهد مصل الهند (SII) تجارب المرحلة II-B3 وسيبدأ تجربة المرحلة الثالثة بعد التصاريح

ক্লিনিকাল ট্রায়াল পর্যায়ে তিনটি COVID-19 টি ভ্যাকসিন, দুটি ভারতে প্রথম পর্যায়ের ট্রায়াল সম্পন্ন করেছে: আইসিএমআর ডিজি
ক্লিনিকাল ট্রায়াল পর্যায়ে তিনটি COVID-19 টি ভ্যাকসিন, দুটি ভারতে প্রথম পর্যায়ের ট্রায়াল সম্পন্ন করেছে: আইসিএমআর ডিজি

সেরাম ইনস্টিটিউট অফ ইন্ডিয়া (এসআইআই) দ্বিতীয় ধাপে-বি 3 ট্রায়াল সম্পন্ন করেছে এবং ছাড়পত্রের পরে দ্বিতীয় ধাপের তৃতীয় বিচার শুরু করবে

Drei COVID-19-Impfstoffe in der klinischen Studienphase, zwei haben die Phase-1-Studie in Indien abgeschlossen: ICMR DG
Drei COVID-19-Impfstoffe in der klinischen Studienphase, zwei haben die Phase-1-Studie in Indien abgeschlossen: ICMR DG

Das Serum Institute of India (SII) hat die Phase-II-B3-Studien abgeschlossen und wird nach Freigabe mit der Phase-III-Studie beginnen